Dermatology Medical Billing: Codes, Modifiers, and Common Denials

Dermatology billing runs on three CPT code families — biopsy, destruction, and excision — plus a separate set of codes for Mohs micrographic surgery. Most dermatology denials do not come from picking the wrong code. They come from billing a biopsy and an excision on the same lesion, leaving off modifier 25 on a same-day office visit, or failing to document medical necessity on something a payer can read as cosmetic.

What CPT codes cover dermatology procedures?

Dermatology coding splits into a handful of families, each with a base code and add-on codes for additional lesions or stages.

Excised diameter for the excision codes is the lesion diameter plus the narrowest margins on each side, measured before anesthesia is injected — not after, and not the size of the resulting defect. Intermediate and complex repairs (12031–13153) are billed separately from the excision itself; they are not bundled into it.

How does the biopsy-to-excision bundling rule work?

If a biopsy and a destruction or excision happen on the same lesion on the same date, you bill the higher-value procedure only. The biopsy is bundled in — it does not get its own line. This trips practices up when the physician biopsies a lesion, gets a quick read, and removes it in the same visit: the instinct is to bill both, and the claim gets denied under a National Correct Coding Initiative (NCCI) edit.

A second, different lesion removed in the same visit is not subject to that bundling rule — but the claim needs to make that clear. Code each lesion separately, and append modifier 59 (or the more specific X-modifier: XE, XS, XP, or XU) to the second procedure line so the payer can see it is a distinct anatomic site, not a duplicate line for the same lesion.

Which modifiers matter most in dermatology claims?

• Modifier 25 — a significant, separately identifiable E/M service on the same day as a procedure. See Modifier 25 Explained for how payers test whether it applies.
• Modifier 59 / XE, XS, XP, XU — overrides an NCCI bundling edit when two procedures on the same date are genuinely distinct (different lesion, different session, or different anatomic site).
• Modifier 76 — a repeat procedure by the same physician in a separate session on the same day.
• Modifier GA — an Advance Beneficiary Notice (ABN) is on file for a service that may be non-covered or cosmetic, preserving the practice’s right to bill the patient if Medicare denies it.

What global period applies to dermatology procedures?

Destruction of benign lesions (17110/17111) carries a 10-day global period, shown as 010 on the fee schedule — routine follow-up in that window is bundled into the procedure and is not billable separately. Mohs surgery codes are the exception: they carry a zero-day global period. That matters for staged Mohs cases, because it means subsequent stages performed the same day do not need modifier 79 to bypass a global period restriction — there is no global period to bypass. A second lesion treated with Mohs the same day, or a repair, biopsy, or frozen section (11102–11107, 88331) billed alongside it, still needs modifier 59 or the relevant X-modifier on its own line.

Why do dermatology claims get denied?

• Bundling errors. Biopsy and excision (or destruction) billed separately on the same lesion, or two procedures hitting an NCCI edit with no modifier to justify separating them.
• Missing or unsupported modifier 25. The E/M line gets bundled into the procedure when the modifier is missing, or the claim gets flagged for audit when the modifier is there but the chart does not document a genuinely separate evaluation.
• Cosmetic designation. Skin tag and benign lesion removal are the most common targets. Payers need documented medical necessity — symptoms such as bleeding, pain, irritation, functional impairment, or a stated concern for malignancy — not just a note that the lesion was removed.
• Undocumented lesion count. Destruction and injection codes (17000/17003, 17110/17111, 11900/11901) are billed per lesion. If the chart does not state the exact number destroyed or injected, the code selection cannot be verified and the claim is vulnerable to downcoding or denial.
• Technique mismatch. Shave, punch, and incisional biopsies are different codes. The op note needs to name the technique used — not just say “biopsy performed” — or the coder is guessing.

These are the same failure modes behind most specialty denials, not something unique to dermatology — see Claim Rejections vs. Claim Denials for how to triage which ones are worth appealing versus fixing at intake.

What’s different about billing Mohs surgery?

Mohs codes (17311–17315) cover both the surgical work and the histopathologic interpretation, and the same physician has to perform both roles to bill them. If a separate pathologist independently bills for reading the Mohs slides, that combination triggers a denial with some payers — UnitedHealthcare denies 17311–17315 outright in that scenario, and the dermatologist can only bill the excision code instead. Stage progression is billed as 17312 or 17314 for stages two through six, then 17315 once tissue blocks exceed five on any stage.

What documentation prevents a denial before it happens?

• Record the biopsy technique by name (shave, punch, or incisional), not just “biopsy.”
• Record lesion size and margins as measured before anesthesia, and note the anatomic location precisely enough to distinguish it from any other lesion treated the same day.
• Record the exact lesion count for destruction and injection codes.
• For modifier 25 claims, write the E/M note as a genuinely separate encounter — its own history, exam, and medical decision-making — not a single sentence appended to the procedure note.
• For anything that could read as cosmetic, document the symptom or clinical concern that made it medically necessary.

Frequently Asked Questions About Dermatology Billing

Do you need modifier 25 for a biopsy performed the same day as an office visit?

Yes, when the office visit involved a significant, separately identifiable evaluation — not just the standard workup that led to the decision to biopsy. If the visit was only the pre-procedure assessment, it is already bundled into the biopsy and modifier 25 does not apply.

Can you bill a biopsy and an excision on the same date?

Only if they are on different lesions. On the same lesion, the biopsy is bundled into the excision and should not be billed separately. On a different lesion, code both procedures and append modifier 59 or the relevant X-modifier to the second line.

What global period applies to Mohs surgery?

Zero days. Mohs codes carry no post-operative global period, which is why additional stages performed the same day do not require modifier 79 — there is no global period restriction to bypass in the first place.

Why would a payer deny a skin tag removal claim?

Most often because the chart does not establish medical necessity. Payers treat skin tag and benign lesion removal as cosmetic by default unless the documentation states a symptom — irritation, bleeding, pain, or a functional problem — that justified removing it.

What OmniBridge Actually Does

We run the parts of the revenue cycle most dermatology practices struggle to staff well: medical coding, claims submission, denial management, and full RCM — built specifically for US physician practices, on a performance-based fee.

If you want to see where your practice currently stands, request a free billing audit and we’ll show you your actual clean claim rate and days in A/R before you commit to anything.

What makes dermatology medical billing difficult?

Dermatology medical billing is difficult because practices often combine office visits, procedures, biopsies, lesion destruction, excisions, pathology coordination, and modifier-sensitive claims. Small documentation gaps can change code selection, payer edits, bundling behavior, and denial risk.

AEO and GEO-ready answer

Dermatology billing teams should verify diagnosis specificity, lesion count and location, procedure size, pathology relationship, global-period rules, modifier use, medical necessity support, and payer-specific edits before submission. The best prevention strategy is to connect clinical documentation, coding review, claim scrubbing, and denial tracking into one repeatable workflow.